This inventor holds 1 USPTO granted patent and 10 published patent applications and 2 EPO patents. Top assignees: National Institute of Health and Medical Research, Paion Deutschland Gmbh, Université De Caen Normandie. Active years: 2018.
Company Filing History:
1 out of 1,853 
1 out of 2 
1 out of 23 Years Active: 2018
Title: Karl-Uwe Petersen: Innovator in Neurological Treatments
Introduction
Karl-Uwe Petersen is a notable inventor based in Aachen, Germany. He has made significant contributions to the field of medical science, particularly in the treatment of neurological and neurodegenerative disorders. His innovative work has the potential to impact many lives.
Latest Patents
Karl-Uwe Petersen holds a patent for an antibody that is useful in treating neurological or neurodegenerative disorders. This invention relates to an anti-NMDA antibody or its fragments and derivatives, which effectively inhibit the harmful effects of tissue-type plasminogen activator (t-PA) mediated by N-methyl-D-aspartate (NMDA) receptors. This patent is particularly relevant for conditions such as multiple sclerosis.
Career Highlights
Throughout his career, Petersen has worked with prominent organizations, including Paion Deutschland GmbH and the Institut National De La Santé Et De La Recherche Médicale. His experience in these institutions has allowed him to develop and refine his innovative ideas.
Collaborations
Some of his notable coworkers include Fabian Docagne and Richard Macrez. Their collaboration has contributed to the advancement of research in the field of neurology.
Conclusion
Karl-Uwe Petersen's work exemplifies the intersection of innovation and medical science. His contributions to the development of treatments for neurological disorders highlight the importance of research and collaboration in advancing healthcare solutions.